Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infusion Pump Errors Top ECRI's Annual Health-Tech Hazards List

Executive Summary

The ECRI Institute identified infusion pump errors as its number-one health-technology hazard for hospitals to look for in 2017, followed by inadequate cleaning of complex reusuable instruments, ventilator alarm management, and infection risks with heater-cooler devices.

You may also be interested in...



FDA Panel Says More Research Needed To Fight Heater-Cooler Infections

The Circulatory System Devices advisory panel generally recommends more frequent cleaning of the devices used to support open-chest surgery and, in the long term, it tasks manufacturers with redesigning them so they are easier to clean and disinfect.

Gamma Camera Failures, Telemetry Shortcomings Added To ECRI's Top Tech Hazards

Gamma camera mechanical failures and surveillance challenges with telemetry-monitored patients monitored are two risks that have been elevated to the nonprofit ECRI Institute's Top 10 technology hazards for the first time in its 2016 listing, while inadequate cleaning of flexible endoscopes and missed alarms on monitoring equipment continue to be highlighted in the annual ranking.

Advanced Imaging Group Calls For Swifter FDA Approvals For Mobile X-Ray, CT, Ultrasound Devices For COVID-19 Crisis

The Medical Imaging & Technology Alliance recently sent a letter to the US FDA recommending steps the agency can take to help the advanced imaging industry quickly respond to the COVID-19 outbreak.

Topics

UsernamePublicRestriction

Register

MT104124

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel